Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors

American Journal of Surgical Pathology

Volumn 33, Issue 3, 2009, Pages 354-366

  Zhao, Chengquan ^a,b   Vinh, Tuyethoa N ^b   McManus, Kim ^a   Dabbs, David ^a   Barner, Ross ^b,e   Vang, Russell ^c,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c Division of Gynecologic Pathology   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Immunohistochemistry; Inhibin; Ovary; Sex cord stromal tumor; SF 1

Indexed keywords

CALRETININ; CD99 ANTIGEN; INHIBIN; MELAN A; STEROIDOGENIC FACTOR 1; WT1 PROTEIN; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; FIBROMA; FIBROTHECOMA; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEYDIG CELL TUMOR; OVARY TUMOR; PROTEIN EXPRESSION; SCORING SYSTEM; SERTOLI CELL TUMOR; SEX CORD TUMOR; THECOMA; FEMALE; METABOLISM; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; SEX CORD-GONADAL STROMAL TUMORS; TUMOR MARKERS, BIOLOGICAL;

EID: 62849125095     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318188373d     Document Type: Article

References (73)

1. Abd-Elaziz M, Moriya T, Akahira J, et al. Immunolocalization of nuclear transcription factors, DAX-1 and Ad4BP/SF-1, in human common epithelial ovarian tumors: correlations with StAR and steroidogenic enzymes in epithelial ovarian carcinoma. Int J Gynecol Pathol. 2005;24:153-163.
2. Agoff SN, Grieco VS, Garcia R, et al. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol. 2001;9:164-169.
3. Aguirre P, Thor AD, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study. Int J Gynecol Pathol. 1989;8:364-373.
4. Anttonen M, Unkila-Kallio L, Leminen A, et al. High GATA-4 expression associates with aggressive behavior, whereas low anti-Mullerian hormone expression associates with growth potential of ovarian granulosa cell tumors. J Clin Endocrinol Metab. 2005; 90:6529-6535.
5. Arora DS, Cooke IE, Ganesan TS, et al. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary. J Pathol. 1997;181:413-418.
6. Asa SL, Bamberger AM, Cao B, et al. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab. 1996;81: 2165-2170.
7. Bamberger AM, Ezzat S, Cao B, et al. Expression of steroidogenic factor-1 (SF-1) mRNA and protein in the human placenta. Mol Hum Reprod. 1996;2:457-461.
8. Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2001;20:346-352.
9. Cathro HP, Stoler MH. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol. 2005;36:195-201.
10. Chadha S, van der Kwast TH. Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers. Virchows Arch A Pathol Anat Histopathol. 1989; 414:439-445.
11. Choi YL, Kim HS, Ahn G. Immunoexpression of inhibin alpha subunit, inhibin/activin beta A subunit and CD99 in ovarian tumors. Arch Pathol Lab Med. 2000;124:563-569.
12. Ciris M, Erhan Y, Zekioglu O, et al. Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences. Acta Obstet Gynecol Scand. 2004;83:491-496.
13. Costa MJ, Morris RJ, Wilson R, et al. Utility of immunohisto-chemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomas. Hum Pathol. 1992;23:787-797.
14. Costa MJ, Morris R, DeRose PB, et al. Histologic and immuno-histochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors. Arch Pathol Lab Med. 1993;117:802-808.
15. Costa MJ, DeRose PB, Roth LM, et al. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value. Hum Pathol. 1994;-25:60-66.
16. Costa MJ, Ames PF, Walls J, et al. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol. 1997;28:1247-1254.
17. de Santa Barbara P, Moniot B, Poulat F, et al. Expression and sub-cellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev Dyn. 2000;217:293-298.
18. Deavers MT, Malpica A, Liu J, et al. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol. 2003;16:584-590.
19. Deavers MT, Malpica A, Ordonez NG, et al. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol. 2003;22:162-167.
20. Devouassoux-Shisheboran M, Silver SA, Tavassoli FA. Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin. Hum Pathol. 1999;30:856-863.
21. Dionigi A, Facco C, Tibiletti MG, et al. Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis. Am J Clin Pathol. 2000;114:111-122.
22. Doglioni C, Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 1996;20:1037-1046.
23. Farinola MA, Gown AM, Judson K, et al. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors. Int J Gynecol Pathol. 2007; 26:375-382.
24. Flemming P, Grothe W, Maschek H, et al. The site of inhibin production in ovarian neoplasms. Histopathology. 1996;29:465-468.
25. Gebhart JB, Roche PC, Keeney GL, et al. Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecol Oncol. 2000; 77:232-236.
26. Gitsch G, Kohlberger P, Hanzal E, et al. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas. Arch Gynecol Obstet. 1991;249:173-177.
27. Gordon MD, Corless C, Renshaw AA, et al. CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis. Mod Pathol. 1998;11:769-773.
28. Guerrieri C, Franlund B, Malmstrom H, et al. Ovarian endome-trioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Int J Gynecol Pathol. 1998;17:266-271.
29. Hanley NA, Ikeda Y, Luo X, et al. Steroidogenic factor 1 (SF-1) is essential for ovarian development and function. Mol Cell Endocrinol. 2000;163:27-32.
30. He H, Luthringer DJ, Hui P, et al. Expression of CD56 and WT1 in ovarian stroma and ovarian stromal tumors. Am J Surg Pathol. 2008;32:884-890.
31. Hildebrandt RH, Rouse RV, Longacre TA. Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum Pathol. 1997;28:1387-1395.
32. Horny HP, Marx L, Krober S, et al. Granulosa cell tumor of the ovary. Immunohistochemical evidence of low proliferative activity and virtual absence of mutation of the p53 tumor-suppressor gene. Gynecol Obstet Invest. 1999;47:133-138.
33. Irving JA, McCluggage WG. Ovarian spindle cell lesions: a review with emphasis on recent developments and differential diagnosis. Adv Anat Pathol. 2007;14:305-319.
34. Kommoss F, Oliva E, Bhan AK, et al. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol. 1998;11:656-664.
35. Lastarria D, Sachdev RK, Babury RA, et al. Immunohistochemical analysis for desmin in normal and neoplastic ovarian stromal tissue. Arch Pathol Lab Med. 1990;114:502-505.
36. Loo KT, Leung AK, Chan JK. Immunohistochemical staining of ovarian granulosa cell tumours with MIC2 antibody. Histopathology. 1995;27:388-390.
37. Lugli A, Forster Y, Haas P, et al. Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol. 2003;34:994-1000.
38. Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol. 1998;29:840-845.
39. McCluggage WG, Maxwell P. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology. 2001;38:403-408.
40. McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol. 2005;22:3-32.
41. McCluggage WG, Maxwell P, Sloan JM. Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin. Hum Pathol. 1997;28:1034-1038.
42. McCluggage WG, Oliva E, Connolly LE, et al. An immunohisto-chemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol. 2004;23:330-336.
43. McCluggage WG, McKenna M, McBride HA. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2007;26: 322-327.
44. Merhi RA, Guillaud L, Delouis C, et al. Establishment and characterization of immortalized ovine Sertoli cell lines. In Vitro Cell Dev Biol Anim. 2001;37:581-588.
45. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cordstromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol. 2002;26:1477-1483.
46. Oliva E, Alvarez T, Young RH. Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2005;29:143-156.
47. Oliva E, Garcia-Miralles N, Vu Q, et al. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohis-tochemical analysis of 101 cases. Int J Gynecol Pathol. 2007;26: 359-367.
48. Ordi J, Schammel DP, Rasekh L, et al. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohisto-chemical study of 13 cases. Mod Pathol. 1999;12:933-940.
49. Otis CN, Powell JL, Barbuto D, et al. Intermediate filamentous proteins in adult granulosa cell tumors. An immunohistochemical study of 25 cases. Am J Surg Pathol. 1992;16:962-968.
50. Ozisik G, Achermann JC, Jameson JL. The role of SF1 in adrenal and reproductive function: insight from naturally occurring mutations in humans. Mol Genet Metab. 2002;76:85-91.
51. Ozisik G, Achermann JC, Meeks JJ, et al. SF1 in the development of the adrenal gland and gonads. Horm Res. 2003;59(suppl 1):94-98.
52. Park SH, Kim I. Histogenetic consideration of ovarian sex cord-stromal tumors analyzed by expression pattern of cytokeratins, vimentin, and laminin. Correlation studies with human gonads. Pathol Res Pract. 1994;190:449-456.
53. Pelkey TJ, Frierson HF Jr, Mills SE, et al. The diagnostic utility of inhibin staining in ovarian neoplasms. Int J Gynecol Pathol. 1998; 17:97-105.
54. Riopel MA, Perlman EJ, Seidman JD, et al. Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas. Int J Gynecol Pathol. 1998; 17:46-53.
55. Rishi M, Howard LN, Bratthauer GL, et al. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol. 1997;21: 583-589.
56. Roth LM. Recent advances in the pathology and classification of ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2006;25: 199-215.
57. Santini D, Ceccarelli C, Leone O, et al. Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia and ovarian granulosa-stromal cells tumors. Mod Pathol. 1995;8:25-30.
58. Sasano H, Kaga K, Sato S, et al. Adrenal 4-binding protein in common epithelial and metastatic tumors of the ovary. Hum Pathol. 1996;27:595-598.
59. Sato Y, Suzuki T, Hidaka K, et al. Immunolocalization of nuclear transcription factors, DAX-1 and COUP-TF II, in the normal human ovary: correlation with adrenal 4 binding protein/steroido-genic factor-1 immunolocalization during the menstrual cycle. J Clin Endocrinol Metab. 2003;88:3415-3420.
60. Seidman JD, Abbondanzo SL, Bratthauer GL. Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity. Int J Gynecol Pathol. 1995;14:331-338.
61. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochem-ical marker. Review of more than 600 tumors and the literature experience. Appl Immunohistochem. 1994;2:231-240.
62. Stewart CJ, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology. 1997;31:67-74.
63. Stewart CJ, Nandini CL, Richmond JA. Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours. J Clin Pathol. 2000;53:206-211.
64. Sumathi VP, Al-Hussaini M, Connolly LE, et al. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Int J Gynecol Pathol. 2004;23:241-247.
65. Tiltman AJ, Haffajee Z. Sclerosing stromal tumors, thecomas, and fibromas of the ovary: an immunohistochemical profile. Int J Gynecol Pathol. 1999;18:254-258.
66. Vang R, Herrmann ME, Tavassoli FA. Comparative immunohistochemical analysis of granulosa and Sertoli components in ovarian sex cord-stromal tumors with mixed differentiation: potential implications for derivation of Sertoli differentiation in ovarian tumors. Int J Gynecol Pathol. 2004;23:151-161.
67. Yao DX, Soslow RA, Hedvat CV, et al. Melan-A (A103) and inhibin expression in ovarian neoplasms. Appl Immunohistochem Mol Morphol. 2003;11:244-249.
68. Young RH, Scully RE. Differential diagnosis of ovarian tumors based primarily on their patterns and cell types. Semin Diagn Pathol. 2001;18:161-235.
69. Zhao C, Barner R, Vinh TV, et al. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian Sertoli cell tumor. Int J Gynecol Pathol. 2008. In Press.
70. Zhao C, Bratthauer GL, Barner R, et al. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian Sertoli cell tumor from endometrioid tumors and carcinoid tumor: a study of 160 cases. Am J Surg Pathol. 2007;31: 255-266.
71. Zhao C, Bratthauer GL, Barner R, et al. Diagnostic utility of WT1 immunostaining in ovarian Sertoli cell tumor. Am J Surg Pathol. 2007;31:1378-1386.
72. Zheng W, Sung CJ, Hanna I, et al. Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers. Int J Gynecol Pathol. 1997;16:263-271.
73. Zheng W, Luo MP, Welt C, et al. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol Oncol. 1998;69:23-31.